High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 601–700 of 865
Kumar, K. J., Yerraguntla, N., Vaddambal, M. G., Juneja, M., Venkatakrishnan, A., Kapoor, S., Jain, R., Jan, S. M. S., Chandrasekaran, A., Balakrishnan, U., et al. (2018) · Indian Pediatrics · doi:10.1007/s13312-018-1408-z · Cited by 7
Molecular characterization of HEPCIDIN-1 (HAMP1) gene in red-bellied pacu (Piaractus brachypomus)
Petano-Duque, J. M., Lozano‐Villegas, K. J., Céspedes-Rubio, Á. E., & Rondón‐Barragán, I. S. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104353 · Cited by 6
Özdemir, E., Stavılecı, B., Özdemir, B., Aksoy, F. A., Kahraman, S., Gevher, C. Z. Ç., Zıyrek, M., & Doğan, A. (2024) · Advances in Medical Sciences · doi:10.1016/j.advms.2024.02.003 · Cited by 6
Prise en charge actuelle des thalassémies intermédiaires
Thuret, I. (2014) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2014.07.005 · Cited by 6
Effects of long‐term ethanol ingestion on hepatic iron metabolism in two mouse strains
Bloomer, S. A., Broadhurst, K. A., Mathahs, M. M., & Brown, K. E. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13445 · Cited by 6
Study of growth differentiation factor-15 in polytransfused children with β-thalassemia
Meena, S., Sharma, K., Sharma, S., & Chandra, J. (2023) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_803_21 · Cited by 6
Erythropoiesis: The Roles of Erythropoietin and Iron
Lin, H. Y.-F. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00002-8 · Cited by 6
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors
Sasaki, Y., Shimonaka, Y., Ikuta, K., Hosoki, T., Sasaki, K., Torimoto, Y., Kanada, H., Moriguchi, Y., & Kohgo, Y. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1476-8 · Cited by 7
“The molecule responsible for hepcidin down-regulation in b-thalassemia was identified as growth differentiation factor (GDF)-15, a transforming growth factor (TGF)-b super family, but GDF-15 is not responsible for physiologic hepcidin regulation [11, 12, 17].”
BackgroundLoréal, O., Bardou‐Jacquet, E., Island, M., Fatih, N., Doyard, M., Détivaud, L., & Brissot, P. (2012) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2012.01.003 · Cited by 7
Sposi, N. M. (2015) · InTech eBooks · doi:10.5772/61716 · Cited by 9
“It was suggested that GDF15 overexpression arising from an expanded erythroid compartment contributed to iron overload in thalassemia syndromes by inhibiting hepcidin expression, possibly by antagonizing the BMP pathway [89,93].”
BackgroundThe role of hepcidin in iron metabolism in inflammatory bowel diseases
Krawiec, P., & Pac‐Kożuchowska, E. (2014) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1111365 · Cited by 7
“Odłączone białko HFE przyłącza się do receptora TfR2 i oddziałując na szlak sygnalizacyjny białek morfogenetycznych kości, stymuluje syntezę hepcydyny [40,54].”
Soluble hemojuvelin in transfused and untransfused thalassaemic subjects
Ferro, E., Pietro, A. D., Visalli, G., Piraino, B., Salpietro, C. D., & Rosa, M. A. L. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12786 · Cited by 6
“GDF15 has been proposed as an ‘erythroid regulator’ that suppresses hepcidin expression in thalassaemia (15).”
BackgroundResultInfluentialKong, W., Cui, Y., Fu, Y., Lei, Y., Ci, Y., Bao, Y., Zhao, S., Xie, L., Chang, Y., & Zhao, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26715 · Cited by 7
Hepatocyte growth factor protects PC12 cells against OGD/R-induced injury by reducing iron
Li, S., Qian, Z., Xu, G.-J., Zheng, J., & Wu, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20200287 · Cited by 6
NOVEL IRON BIOMARKERS IN CHRONIC KIDNEY DISEASE
Zapora-Kurel, A., & Małyszko, J. (2021) · Wiadomości Lekarskie · doi:10.36740/wlek202112119 · Cited by 6
Serum erythroferrone diagnostic value in patients with beta-thalassemia with iron overload
Saeed, A. M., Nabil, N., Elsalakawy, W. A., Metwali, R., Khattab, A., & Naguib, M. G. (2021) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_22_21 · Cited by 5
Exploring the Impact of Iron Overload on Mitochondrial DNA in β-Thalassemia: A Comprehensive Review
Narahari, J. M., Guruswamy, P., Jagadeesha, N. M., Shivashakar, K. K., Kumar, D. P., Narayana, P. S., Vishwanath, P. M., & Prashant, A. (2024) · Gene Expression · doi:10.14218/ge.2023.00128 · Cited by 15
A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression
Kawabata, H., Uchiyama, T., Sakamoto, S., Kanda, J., Oishi, S., Fujii, N., Tomosugi, N., Kadowaki, N., & Takaori‐Kondo, A. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.01.005 · Cited by 5
Moosig, F., Reinhold‐Keller, E., Holl‐Ulrich, K., Feller, A. C., Bley, T. A., Holle, J. U., Zwerina, J., Lamprecht, P., Dalhoff, K., Venhoff, N., et al. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-0988-6 · Cited by 7
Loréal, O., Ropert, M., Doyard, M., Island, M., Fatih, N., Détivaud, L., Bardou‐Jacquet, E., & Brissot, P. (2012) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(12)71455-7 · Cited by 11
Iron clad: iron homeostasis and the diagnosis of hereditary iron overload
Heeney, M. M. (2014) · Hematology · doi:10.1182/asheducation-2014.1.202 · Cited by 5
The Cellular Physiology of Iron
Anderson, G. J., & Vulpe, C. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_1 · Cited by 7
Prognostic Impact of Serum Growth Differentiation Factor 15 Level in Acute Myeloid Leukemia Patients
Hegab, H. M. A.-A., El-Ghammaz, A. M. S., Razzaz, M. E., & Helal, R. (2020) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-020-01315-7 · Cited by 5
Vadolas, J., Nualkaew, T., Voon, H. P. J., Vilcassim, S., & Grigoriadis, G. (2024) · HemaSphere · doi:10.1002/hem3.78 · Cited by 5
“59,60 In this situation, dietary iron absorption, and availability is increased, which contributes to systemic iron overload and increased ROS production, ultimately causing end ‐ organ damage.”
BackgroundWang, X., Lenartowicz, M., Mazgaj, R., Ogłuszka, M., Szkopek, D., Zaworski, K., Kopeć, Z., Żelazowska, B., Lipiński, P., Woliński, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011215 · Cited by 6
“Contrary to iron, hepcidin expression can be suppressed by secreted erythroid factors, such as erythroferrone [38] and GDF15 [39].”
BackgroundTransfusion and Iron Chelation Therapy in Thalassemia and Sickle Cell Disease
Kwiatkowski, J. L., & Porter, J. B. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.040 · Cited by 6
Clinical Use of Iron Chelators
Porter, J. B., & Hershko, C. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_28 · Cited by 8
Bao, W., Zhong, H., & Yazdanbakhsh, K. (2014) · Transfusion · doi:10.1111/trf.12683 · Cited by 5
Halawi, R., Motta, I., Taher, A. T., & Cappellini, M. D. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1182018 · Cited by 5
“involved, namely growth differentiation factor 15 in humans (a cytokine member of the TGF-β family) [19] and twisted gastrulation protein homolog 1 in mice.”
BackgroundMolecular Effects of Alcohol on Iron Metabolism
Mehta, K. J., Farnaud, S., & Patel, V. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800773-0.00028-8 · Cited by 6
Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8
Upanan, S., McKie, A. T., Latunde-Dada, G. O., Roytrakul, S., Uthaipibull, C., Pothacharoen, P., Kongtawelert, P., Fucharoen, S., & Srichairatanakool, S. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2231-3 · Cited by 7
Self-citationInfluence of esophageal variceal bleeding on iron status in chronic hepatitis C patients
Abbas, O. M., Khalifa, K. A. E., Makhlouf, M. M., Osman, N., Abdel‐Razek, W., & Atta, A. S. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001547 · Cited by 5
ghazala, M., Abdellateif, S., Taher, M., Abdelmohsen, E., Bakheet, O. H., & Assem, A. A. A. (2021) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2021.64501.1422 · Cited by 5
Tenenbein, M., & Huang, X. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822946-0.00016-7 · Cited by 5
Gung, Y.-T.-A., Kondo, H., Aoki, T., & Hırono, I. (2008) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2008.11.006 · Cited by 5
Diseased red blood cells topple iron balance
Chou, S. T., & Weiss, M. J. (2007) · Nature Medicine · doi:10.1038/nm0907-1020 · Cited by 5
Surcharges héréditaires en fer
Brissot, P., Bardou‐Jacquet, E., Latournerie, M., Ropert, M., Island, M., Loréal, O., & Jouanolle, A. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.10.011 · Cited by 6
Proximate and ultimate causes of pregnancy sickness
Stadtmauer, D. J. (2025) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaf025 · Cited by 4
“Women with beta thalassemia, a condition associated with persistently high circulating GDF15 levels, also show a more than 90% reduction in incidence of NVP [22 , 208 ].”
Saeidnia, M., Fazeli, P., Farzi, A., Nezhad, M. A., Shabani-Borujeni, M., Erfani, M., Tamaddon, G., & Karimi, M. (2023) · Hemoglobin · doi:10.1080/03630269.2022.2158099 · Cited by 7
“Disequilibrium between b-globin chains along with ineffective erythropoiesis and elevated HIF-1a factor (owing to chronic anemia) could result in rising GDF-15 factor, EPO, and increased ferroprotein channel permeability; following that, hepcidin that controls iron absorption is suppressed via GDF-15 and as a conseque…”
BackgroundInfluentialSinlapamongkolkul, P., Surapolchai, P., & Viprakasit, V. (2023) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2023.056 · Cited by 6
Wu, J., Liu, J., Chen, J., Yang, L., Li, F., Qin, T., Xu, Z., Liu, J., Zhou, J., Shi, L., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00664-1 · Cited by 4
Maltaneri, R. E., Chamorro, M. E., Gionco, S., Nesse, A. B., & Vittori, D. C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119800 · Cited by 5
Shen, M., Guo, Q., Li, W., & Qian, Z. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00290-7 · Cited by 4
“Together, these fi ndings provide further evidence for the close link between iron and macrophage polarization and the important role of ApoE in body iron homeostasis, and also imply that reduced or absent ApoE expression may be associated with clinically unexplained increases in iron in the body.”
Need for early recognition and therapeutic guidelines of congenital sideroblastic anaemia
Cuijpers, M. L. H., van Spronsen, D. J., Muus, P., Hamel, B. C. J., & Swinkels, D. W. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0875-y · Cited by 4
“the macrophages, leading to parenchymal iron overload and tissue damage [2–5].”
BackgroundTherapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
Hagag, A. A. E. (2014) · Journal of Leukemia · doi:10.4172/2329-6917.1000132 · Cited by 5
“Hepcidin deficiency in thalassemia intermedia may be the key factor allowing excessive iron absorption and development of iron overload in this milder form of anemia that remain mostly transfusion independent, but develop iron overload [12-16].”
BackgroundAllogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: Critical for Cure?
de Witte, T. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.04.003 · Cited by 4
Dokuyucu, R., Demir, T., Yumrutaş, Ö., Erbağcı, A. B., Örkmez, M., Bahar, A. Y., Bayraktar, R., Bozgeyik, İ., Kaplan, D. S., Cengiz, B., et al. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1307-100 · Cited by 4
“(BMPs), and growth differentiation factor 15 (GDF-15) are related to the expression of hepcidin (6,7).”
BackgroundIron metabolism and diagnosis of iron overload disorders
Dever, J. B., & Kowdley, K. V. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903440138 · Cited by 4
“An iron-free diet, iron deficiency anemia, growth differentiation factor 15 (GDF15), alcohol and hypoxia are associated with decreased hepcidin production [25,26].”
BackgroundIron Deficiency, Iron Overload and Therapy
Crichton, R. R. (2016) · Wiley eBooks · doi:10.1002/9781118925645.ch11 · Cited by 4
Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts
Jaratsittisin, J., Sornjai, W., Svasti, S., Fucharoen, S., Roytrakul, S., & Smith, D. R. (2017) · Hematology · doi:10.1080/10245332.2017.1405571 · Cited by 4
“patients [14] and on studies undertaken in mice [15,16], and plasma is known as a complex fluid whose composition is influenced by many cells [21].”
BackgroundInfluentialSelf-citationUaprasert, N., Satitthummanid, S., Akkawat, B., Sutcharitchan, P., & Rojnuckarin, P. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.12.021 · Cited by 4
Pietrangelo, A., & Torbenson, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00004-2 · Cited by 9
[Expression of iron-regulating erythroid factors in different types of erythropoiesis disorders].
Liu, X., Hu, J. Y., Hu, X., Li, X. X., Guan, D., Liu, J. Q., Zhang, Y. L., & Zhang, F. K. (2021) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2021.01.010 · Cited by 4
“[2] Tanno T, Bhanu NV, Oneal PA, et al.”
BackgroundBordoni, V., Casale, M., Pinto, V. M., Carsetti, R., Gianesin, B., Gamberini, M. R., Mazdai, L., Barella, S., Denotti, A. R., Colavita, F., et al. (2023) · American Journal of Hematology · doi:10.1002/ajh.26905 · Cited by 4
Molecular Regulation of Systemic Iron Metabolism
Ganz, T., & Vaulont, S. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_9 · Cited by 6
Self-citationRoggero, S., Vullo, S., Volpe, G., Piga, A. G., & Albera, C. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-014-1073-6 · Cited by 4
“GDF15 expression is associated with cellular stress or apoptosis and may be a marker of multiple stress pathway; ineffective erythropoiesis cause high-level expression of GDF15 in thalassemic patients [15].”
BackgroundGDF15 coupable de l’hypersidérémie des patients thalassémiques par extinction de l’hepcidine
Vaulont, S., & Labie, D. (2008) · médecine/sciences · doi:10.1051/medsci/2008242139 · Cited by 4
“ont émis l’hypothèse selon laquelle l’expansion du compartiment érythroïde chez les patients pourrait être à l’origine de la régulation de l’hepcidine via la sécrétion de membres de la famille des facteurs de croissance TGFβ qui sont naturellement sécrétés au cours de l’erythropoïèse [13].”
Ishaq, M., & Ahmed, F. S. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-466 · Cited by 4
“GDF-15 inhibits hepcidin gene expression, which in turn increases iron absorption from the gastrointestinal tract [11].”
BackgroundGaur, P., Saini, S., Ray, K., Kishore, K., Asanbekovna, K. N., Akunov, A., Maripov, A., Sharma, Y. K., Sharma, S. K., Kumar, B., et al. (2020) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2020.10.001 · Cited by 4
Luspatercept: From Bench to Bedside and Beyond in the Management of Ineffective Erythropoiesis
Popat, D., Desai, R., Abdullah, S., Jain, S., & Ramadas, P. (2026) · Journal of Hematology · doi:10.14740/jh2163 · Cited by 3
“Growth differentiation factor-15 (GDF-15) is elevated and suppresses hepcidin, promoting intestinal iron absorption and contributing to iron overload [9].”
Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities
Akı, Ş. Z., Paşaoğlu, H., Yeğin, Z. A., Suyanı, E., Yılmaz, C., Özkurt, Z. N., Yağcı, M., & Sucak, G. T. (2011) · Hematology · doi:10.1179/102453311x13085644680023 · Cited by 3
Song, N.-S. J., & Yoshizaki, K. (2012) · Inflammation and Regeneration · doi:10.2492/inflammregen.32.099 · Cited by 3
Recapitulating Hematopoietic Development in a Dish
Vanuytsel, K., Steinberg, M. H., & Murphy, G. J. (2019) · Current human cell research and applications · doi:10.1007/978-981-13-3672-0_4 · Cited by 3
The associations between red cell distribution width and plasma proteins in a general population
Pan, J., Borné, Y., Orho‐Melander, M., Nilsson, J. Å., Melander, O., & Engström, G. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09319-9 · Cited by 3
“GDF-15 has a role in regulation of iron homeostasis [30] and it has been shown that GDF-15 expression is regulated by hypoxia [31] and iron depletion [32].”
BackgroundNeonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators
Tsuge, M., Kodera, A., Sumitomo, H., Araki, T., Yoshida, R., Yasui, K., Sato, H., Washio, Y., Washio, K., Shigehara, K., et al. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03706-3 · Cited by 3
“Serum GDF-15 and serum erythroferrone levels in thalassemia patients have been reported to be high [25, 26], and in this case, serum GDF-15 levels before liver transplantation were high.”
BackgroundTransfusion avoidance in myelodysplastic neoplasms
Griffiths, E. A. (2023) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000794 · Cited by 3
Hepcidin: A potent antimicrobial peptide involved in iron homeostasis
Soofiyani, S. R., Soltani, E., Nejad, M. K., Ghanbari, R., & Memar, M. Y. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.102082 · Cited by 3
Anemia of inflammation: clinical insights from mechanisms.
Means, R. T. (2013) · PubMed · Cited by 4
Brătescu, L., Bârsan, L., Gârneaţă, L., Stanciu, A., Lipan, M., Stancu, S. H., & Mircescu, G. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0696-z · Cited by 3
A transcriptome-based examination of blood group expression
Noh, S.-J., Lee, Y. T., Byrnes, C., & Miller, J. L. (2010) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2010.06.010 · Cited by 3
“To generate the erythroblast transcript profiles, the cells were isolated in high purity [14,15].”
Self-citationGenetics of hereditary hemochromatosis: a clinical perspective
Gan, E. K., Trinder, D., Ayonrinde, O. T., & Olynyk, J. K. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.9 · Cited by 3
Iron overload in myelodysplastic syndromes
Chodirker, L., & Wells, R. A. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.23 · Cited by 4
The Role of Hepcidin in Iron Homeostasis
Ganz, T. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_3 · Cited by 3
“GDF15, a member of the TGFb/BMP family of ligands, is produced by erythrocyte precursors and is present at very high concentrations in the plasma of patients with b-thalassemia (Tanno et al., 2007).”
BackgroundSelf-citationInherited Hemoglobin Disorders
Munshi, A. (2015) · InTech eBooks · doi:10.5772/59742 · Cited by 3
Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationship
Cazzola, M., & Invernizzi, R. (2010) · Haematologica · doi:10.3324/haematol.2009.021683 · Cited by 3
Rahaman, M., Bhowmick, C., Komanapalli, J., Mukherjee, M., Byram, P. K., Shukla, P. C., Dolai, T. K., & Chakravorty, N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.13.464339 · Cited by 4
“All the three datasets, i.e. GSE13284, GSE7874 and GSE71935, were combined and implemented training-validation approach, in which 75% of the datawas employed for training and the rest 25% was used for testing.”
BackgroundMethodInfluentialHepcidin: A multifaceted hormone in iron homeostasis and tumor biology
Liu, X., Zhang, X., Fan, Y., & Tan, K. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.10.003 · Cited by 3
NAG-1/GDF15 modulates hepcidin expression through STAT3 and SMAD pathways
Lertpatipanpong, P., Krisanapun, C., Boonruang, K., Jung, Y. J., & Baek, S. J. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110724 · Cited by 2
Peng, B., Zhao, W., Kong, M., Chen, Y., & Sun, C. (2026) · British Journal of Biomedical Science · doi:10.3389/bjbs.2026.16085 · Cited by 2
“…(5) High GDF-15 inhibits the expression of hepcidin and mediates iron overload by regulating forkhead box protein O3a (FoxO3a) expression through the reactive oxygen species (ROS)/PI3K/ Akt axis in humans; iron overload itself has also been reported to independently induce muscle atrophy [77, 78].”
Relationship Between Iron and Erythropoiesis
Sposi, N. M. (2012) · Contact-less Assessment of In-vivo Body Signals Using Microwave Doppler Radar (InTech) · doi:10.5772/33246 · Cited by 2
“Also GDF15 could be another potential therapeutic target for beta-thalassemia syndromes (Tanno et al., 2007).”
BackgroundInfluentialSłomka, A., Koba, M., Kulwas, A., & Żekanowska, E. (2011) · Current Pharmaceutical Analysis · doi:10.2174/157341211796353309 · Cited by 3
“Growth differentiation factor 15 is a member of the transforming growth factor- super-family, the concentration of which is increased in patients with thalassemia, which causes inhibition of hepcidin expression [37].”
BackgroundSilvestri, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00037-6 · Cited by 4
Erythroferron: Modern Concepts of Its Role in Iron Metabolism Regulation
Sakhin, V. T., Kremneva, N. V., Гордиенко, А. В., & Rukavitsyn, O. A. (2017) · Clinical oncohematology · doi:10.21320/2500-2139-2017-10-1-25-28 · Cited by 2
“у данной категории больных выявлен повышенный уровень этого белка в крови [9, 15].”
Nakamura, Y., Ohsawa, I., Goto, Y., Namba, H., Dodo, Y., Tsuji, M., Kiuchi, Y., Inagaki, M., & Gotoh, H. (2017) · Internal Medicine · doi:10.2169/internalmedicine.8809-17 · Cited by 2
“7 pg/mL, reference normal average; 450±50 pg/mL) (15) decreased along with the decrease of NT-proBNP after treatment.”
BackgroundHepcidin-mediated regulation of iron metabolism in Myelodysplastic syndrome
Dudina, G. A. (2018) · Malignant tumours · doi:10.18027/2224-5057-2018-8-1-48-54 · Cited by 2
TGF beta Superfamily Cytokine MIC-1/GDF15 in Health and Inflammatory Diseases
Breit, S. N., & Brown, D. A. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_54 · Cited by 2
Yamaguchi, A., Hirano, I., Narusawa, S., Shimizu, K., Ariyama, H., Yamawaki, K., Nagao, K., Yamamoto, M. P., & Shimizu, R. (2021) · Genes to Cells · doi:10.1111/gtc.12887 · Cited by 2
Hossaini, S. K. E., Haeri, M. R., & Seif, F. (2022) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-022-01533-1 · Cited by 2
“Reduced concentration of hepcidin by an erythropoietic mechanism causes iron overload in the TI patients, in the absence of blood transfusions [16].”
BackgroundChansai, S., Yamsri, S., Fucharoen, S., Fucharoen, G., & Teawtrakul, N. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.052 · Cited by 2
“Increased GDF15 levels in these patients decrease iron overload by increasing intestinal iron absorption.(4) High GDF15 levels also correlate with clinical severity in transfusiondependent thalassemia.”
Self-citationMatsuoka, T., Tomita, H., Tagami, T., Maruyama, N., Yasuo, M., Nagura, C., Tsunemi, A., Nakamura, Y., Maruyama, T., Abe, M., et al. (2025) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.70040 · Cited by 2
Atar, R., Dayer, D., Far, M. A. J., Keikhaei, B., & Asadi, Z. T. (2021) · Clinical Cancer Investigation Journal · doi:10.51847/15mq0q6jdfo901 · Cited by 4
Érythropoïèse et métabolisme du fer: interactions et applications biomédicales
Dine, G., Fumagalli, G., Lierde, F. V., & Genty, V. (2010) · Bio Tribune Magazine · doi:10.1007/s11834-010-0139-9 · Cited by 2
Canavesi, E., & Valenti, L. V. C. (2011) · InTech eBooks · doi:10.5772/22735 · Cited by 4
Disorders of Red Cell Production and the Iron-Loading Anemias
Rivella, S. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_16 · Cited by 2
“Compared to controls, GDF15 is elevated in the serum of beta-thalassemic patients and suppresses hepcidin expression in vitro [ 181 ] .”
BackgroundSerum prohepcidin level in myelodysplasia
Husseiny, N. M. E., Mattar, M., Sabry, R., & Amin, I. S. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.488700 · Cited by 2
Current possibilities of chelation therapy
Сметанина, Н. С. (2015) · Russian Journal of Pediatric Hematology and Oncology · doi:10.17650/2311-1267-2014-0-1-51-61 · Cited by 2
Brissot, P., Bardou‐Jacquet, E., Latournerie, M., Bridoux‐Henno, L., Jouanolle, A., & Loréal, O. (2013) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(12)61600-7 · Cited by 2
Hepcidin and the Hormonal Control of Iron Homeostasis
Frazer, D. M., & Anderson, G. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00015-4 · Cited by 3
Differential diagnosis of anemia in pregnant women
Prokhorenko, T. S., Zima, A. P., Саприна, Т. В., Мусина, Н. Н., Shakhmanova, N. S., & Novitsky, V. V. (2017) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2017-1-140-151 · Cited by 3
Expression of fluorescent tagged recombinant erythroferrone protein
Srichairatanakool, S., Than, M. M., Ruangsuriya, J., & Uthaipibull, C. (2018) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.237079 · Cited by 2
“Some studies showed hepcidin gene suppression was caused by bone marrow secreted growth differentiation factors 15[13,14] and twisted gastrulation protein homolog 1[15].”
Background
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.